Scinovex
review Open AccessTop 1% cited

Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates

BMJ Open · 2014 · Vol. 4(3) · pp. e003901–e003901
Sam WattsGeraldine LeydonBrian BirchPhilip PrescottLily LaiSusan EardleyGeorge Lewith

Abstract

Our findings suggest that the prevalence of depression and anxiety in men with prostate cancer, across the treatment spectrum, is relatively high. In light of the growing emphasis placed on cancer survivorship, we consider that further research within this area is warranted to ensure that psychological distress in patients with prostate cancer is not underdiagnosed and undertreated.

Cancer survivorship and careOptimism, Hope, and Well-beingFamily Support in IllnessMedicineMeta-analysisAnxietyProstate cancerDepression (economics)EpidemiologySystematic reviewCancerMEDLINEFamily medicine

MeSH terms

AnxietyAnxiety DisordersDepressionDepressive DisorderHumansMaleProstatic NeoplasmsStress, PsychologicalPrevalence

Funding

  • National Institute for Health and Care Research
Citations
463
FWCI
11.48
field-weighted impact
References
79
Percentile
99%
vs. same field & year
Citations per year
References
An Inventory for Measuring Depression
Archives of General Psychiatry · 1961 · 37,929 citations
Depression Is a Risk Factor for Noncompliance With Medical Treatment
Archives of Internal Medicine · 2000 · 4,123 citations
The Hospital Anxiety and Depression Scale
Acta Psychiatrica Scandinavica · 1983 · 46,029 citations
A Self-Rating Depression Scale
Archives of General Psychiatry · 1965 · 9,566 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates · Scinovex